Headlines

Wheeler Bio welcomes Charles River's flexible testing lab to Oklahoma site

CDMO Wheeler Bio, Inc. has welcomed Charles River’s flexible biologics testing lab, RightSource, to its Oklahoma City drug substance manufacturing site.

London start-up Lindus Health announces trials for insomina, tinnitus and short-sightedness

A London-based start-up that says clinical trials are ‘the biggest bottleneck to improving human health’ is launching a number of ‘breakthrough’ treatments for conditions including tinnitus, insomnia and progressive childhood short-sightedness.

Cumulus Neuroscience completes enrollment for Alzheimer's multi-site study

A study looking at the feasibility of using repeated sampling of validated digital measures at home, in patients with early-stage Alzheimer’s Disease (AD), has completed enrollment for a multi-site study.

Single tablet treatment on the horizon for pulmonary arterial hypertension

Patients with pulmonary arterial hypertension (PAH) may be able to take a single tablet instead of multiple types if a new drug is approved.

Wearable monitor a 'game changer' in Parkson's fight, study shows

Studies show a wearable monitor, described as a ‘game changer’ in the fight against Parkinson’s Disease (PD) has proven it is more than 95% accurate, PD Neurotechnology says.

Algiax Pharmaceuticals 'convinced' they can provide new treatment for chronic pain relief

A small molecule drug candidate from Algiax Pharmaceuticals can reduce excitability of neurons in relation to chronic pain, dampening signal and reducing pain, a study shows.